Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversiesJosé María García Ruiz de Morales, Miguel Á. González‐Gay, E. Daudén et al.|Autoimmunity Reviews|2019Cited by 334
Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based studySatveer K. Mahil, Anthony Bewley, Nick Dand et al.|Journal of Allergy and Clinical Immunology|2020Cited by 160
Treatment of patients with plaque psoriasis with secukinumab in a real-life setting: a 52-week, multicenter, retrospective study in SpainJ. Notario, Marta Ferrán, D. Vidal et al.|Journal of Dermatological Treatment|2018Cited by 74
Exploring the Role of IL-36 Cytokines as a New Target in Psoriatic DiseaseHelena Iznardo, L. Puig|International Journal of Molecular Sciences|2021Cited by 72
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre StudyTiago Torres, Paolo Gisondi, Andrea Chiricozzi et al.|American Journal of Clinical Dermatology|2024Cited by 58